Panamerican Sports Med Inst is categorized under Sports Medicines in Miami, FL and active since 2005.
Panamerican Sports Med Inst was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Alex Rojas, Office Manager at the company’s single location by writing to 3850 Sw 87th Avenue, Miami, Florida FL 33165 or by phoning (305) 227-3350. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Panamerican Sports Med Inst |
| Contact Person: | Alex Rojas, Office Manager |
| Address: | 3850 Sw 87th Avenue, Miami, Florida 33165 |
| Phone Number: | (305) 227-3350 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Panamerican Sports Med Inst was started in 2005 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Alex Rojas, Office Manager for inquiries that concern Panamerican Sports Med Inst by calling the company number (305) 227-3350, as your correspondence is most welcome. Additionally, the physical location of the single location of Panamerican Sports Med Inst can be found at the coordinates 25.73416,-80.33593 as well as the street address 3850 Sw 87th Avenue in Miami, Florida 33165.
For its online presence, you may visit Panamerican Sports Med Inst’s website at and engage with its social media outlets through on Twitter and on Facebook.